. 2015 Nov 5;14:58. doi: 10.1186/s12904-015-0056-5

Table 2.

Clinical outcomes and complications

	NG tube	Esophageal stent	NPO	P-value
	(n = 12)	(n = 10)	(n = 9)
Albumin, g/dL	3.1 ± 0.5	3.0 ± 0.5	2.1 ± 0.4	<0.01
EN intake, dL/day	11.8 ± 4.9	10.9 ± 3.5	3.6 ± 1.9	0.01
IV fluid volume, dL/day	9.9 ± 4.9	9.4 ± 3.7	13.5 ± 3.3	0.08
LOH, days	19 ± 15	12 ± 11	39 ± 18	0.01
Survival, days	122^a	133^a	51	<0.01
Complications	22	21	9
Aspiration pneumonia	7^b	5^b	9	0.38
Dislodgment	7^c	2^c	0	0.01
Chest pain	2	3	0	0.21
Perforation	0	0	0
Hemorrhage	0	0	0

^a p = 0.56 between NG tube group and esophageal stent group. ^b p = 0.63 between NG tube group and esophageal stent group. ^c p = 0.01 between NG tube group and esophageal stent group. NG tube nasogastric tube, NPO nil per os, EN enteral nutrition, PN parenteral nutrition, LOH length of hospital stay, IV intravenous